Phosphotyrosine signaling proteins that drive oncogenesis tend to be highly interconnected

Molecular and Cellular Proteomics

Volumn 12, Issue 5, 2013, Pages 1204-1213

  Koytiger, Grigoriy ^a,b   Kaushansky, Alexis ^b,c   Gordus, Andrew ^b,d   Rush, John ^e   Sorger, Peter K ^a   MacBeath, Gavin ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e CELL SIGNALING TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; PHOSPHOTYROSINE; PROTEIN SH2; PROTEIN TYROSINE KINASE; TYROSINE;

ARTICLE; BINDING AFFINITY; CARCINOGENESIS; GENOME; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

CARCINOGENESIS; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ONCOGENE PROTEINS; PHOSPHOTYROSINE; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 84877628735     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.025858     Document Type: Article

References (64)

1. Lemmon, M. A., and Schlessinger, J. (2010) Cell signaling by receptor tyrosine kinases. Cell 141, 1117-1134
2. Liu, B. A., Jablonowski, K., Raina, M., Arcé, M., Pawson, T., and Nash, P. D. (2006) The Human and Mouse Complement of SH2 Domain Proteins-Establishing the Boundaries of Phosphotyrosine Signaling. Mol. Cell 22, 851-868
3. Jones, R. B., Gordus, A., Krall, J. A., and MacBeath, G. (2006) A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439, 168-174 (Pubitemid 43083134)
4. Salcini, A. E., McGlade, J., Pelicci, G., Nicoletti, I., Pawson, T., and Pelicci, P. G. (1994) Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 9, 2827-2836 (Pubitemid 24296757)
5. Esposito, D. L., Li, Y., Cama, A., and Quon, M. J. (2001) Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. Endocrinology 142, 2833-2840 (Pubitemid 32575518)
6. Marshall, C. J. (1995) Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185
7. Santarius, T., Shipley, J., Brewer, D., Stratton, M. R., and Cooper, C. S. (2010) A census of amplified and overexpressed human cancer genes. Nat. Rev. Cancer 10, 59-64
8. Perren, T. J. (1991) c-erbB-2 oncogene as a prognostic marker in breast cancer. Br. J. Cancer 63, 328-332
9. McIntyre, A., Summersgill, B., Grygalewicz, B., Gillis, A. J., Stoop, J., van Gurp, R. J., Dennis, N., Fisher, C., Huddart, R., Cooper, C., Clark, J., Oosterhuis, J. W., Looijenga, L. H., and Shipley, J. (2005) Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res. 65, 8085-8089 (Pubitemid 41330569)
10. Comoglio, P. M., Giordano, S., and Trusolino, L. (2008) Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat. Rev. Drug Discovery 7, 504-516 (Pubitemid 351767118)
11. Mulligan, L. M., Kwok, J. B., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., and Papi, L. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363, 458-460 (Pubitemid 23179393)
12. Hofstra, R. M., Landsvater, R. M., Ceccherini, I., Stulp, R. P., Stelwagen, T., Luo, Y., Pasini, B., Höppener, J. W., van Amstel, H. K., and Romeo, G. (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367, 375-376
13. Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., Tunio, G., Matsuzawa, Y., Kanakura, Y., Shinomura, Y., and Kitamura, Y. (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577-580 (Pubitemid 28067289)
14. Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., and Talpaz, M. (2001) Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N. Engl. J. Med. 344, 1038-1042 (Pubitemid 32267973)
15. Cheung, L. W., Hennessy, B. T., Li, J., Yu, S., Myers, A. P., Djordjevic, B., Lu, Y., Stemke-Hale, K., Dyer, M. D., Zhang, F., Ju, Z., Cantley, L. C., Scherer, S. E., Liang, H., Lu, K. H., Broaddus, R. R., and Mills, G. B. (2011) High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cancer Discovery 1, 170-185
16. Liu, Y. Y., Slotine, J. J., and Barabási, A. L. (2011) Controllability of complex networks. Nature 473, 167-173
17. Jonsson, P. F., and Bates, P. A. (2006) Global topological features of cancer proteins in the human interactome. Bioinformatics 22, 2291-2297 (Pubitemid 44390886)
18. Wachi, S., Yoneda, K., and Wu, R. (2005) Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 21, 4205-4208 (Pubitemid 41724298)
19. Hakes, L., Robertson, D. L., and Oliver, S. G. (2005) Effect of dataset selection on the topological interpretation of protein interaction networks. BMC Genomics 6, 131
20. Hakes, L., Pinney, J. W., Robertson, D. L., and Lovell, S. C. (2008) Protein-protein interaction networks and biology-what's the connection? Nat. Biotechnol. 26, 69-72
21. Phizicky, E., Bastiaens, P. I., Zhu, H., Snyder, M., and Fields, S. (2003) Protein analysis on a proteomic scale. Nature 422, 208-215 (Pubitemid 36362758)
22. Mayer, B. J., Blinov, M. L., and Loew, L. M. (2009) Molecular machines or pleiomorphic ensembles: signaling complexes revisited. J. Biol. 8, 81
23. Huang, H., Li, L., Wu, C., Schibli, D., Colwill, K., Ma, S., Li, C., Roy, P., Ho, K., Songyang, Z., Pawson, T., Gao, Y., and Li, S. S.-C. (2008) Defining the specificity space of the human src homology 2 domain. Mol. Cell. Proteomics 7, 768-784 (Pubitemid 351597486)
24. Rodriguez, M., Li, S. S., Harper, J. W., and Songyang, Z. (2004) An oriented peptide array library (OPAL) strategy to study protein-protein interactions. J. Biol. Chem. 279, 8802-8807 (Pubitemid 38295938)
25. Zhou, S., Shoelson, S. E., Chaudhuri, M., Gish, G., Pawson, T., Haser, W. G., King, F., Roberts, T., Ratnofsky, S., Lechleider, R. J. (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778 (Pubitemid 23093884)
26. Liu, B. A., Jablonowski, K., Shah, E. E., Engelmann, B. W., Jones, R. B., and Nash, P. D. (2010) SH2 domains recognize contextual peptide sequence information to determine selectivity. Mol. Cell Proteomics 9, 2391-2404
27. Gorelik, M., Stanger, K., and Davidson, A. R. (2011) A Conserved residue in the yeast Bem1p SH3 domain maintains the high level of binding specificity required for function. J. Biol. Chem. 286, 19470-19477
28. Kaushansky, A., Allen, J. E., Gordus, A., Stiffler, M. A., Karp, E. S., Chang, B. H., and MacBeath, G. (2010) Quantifying protein-protein interactions in high throughput using protein domain microarrays. Nat. Protoc. 5, 773-790
29. Lemmon, M. A., and Schlessinger, J. (2010) Cell signaling by receptor tyrosine kinases. Cell 141, 1117-1134
30. Kaushansky, A., Gordus, A., Budnik, B. A., Lane, W. S., Rush, J., and MacBeath, G. (2008) System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties. Chem. Biol. 15, 808-817
31. Jung, A. S., Kaushansky, A., Macbeath, G., and Kaushansky, K. (2011) Tensin2 is a novel mediator in thrombopoietin (TPO)-induced cellular proliferation by promoting Akt signaling. Cell Cycle 10, 1838-1844
32. Mehlitz, A., Banhart, S., Mäurer, A. P., Kaushansky, A., Gordus, A. G., Zielecki, J., Macbeath, G., and Meyer, T. F. (2010) Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1. J. Cell Biol. 190, 143-157
33. Boettcher, J. P., Kirchner, M., Churin, Y., Kaushansky, A., Pompaiah, M., Thorn, H., Brinkmann, V., Macbeath, G., and Meyer, T. F. (2010) Tyrosine-phosphorylated caveolin-1 blocks bacterial uptake by inducing Vav2-RhoA-mediated cytoskeletal rearrangements. PLoS Biol. 8
34. Huber, P. J. (2003) Robust Statistics, John Wiley & Sons
35. Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., and Stratton, M. R. (2004) A census of human cancer genes. Nature Reviews Cancer 4, 177-183 (Pubitemid 38337497)
36. Huret, J. L., Minor, S. L., Dorkeld, F., Dessen, P., and Bernheim, A. (2000) Atlas of genetics and cytogenetics in oncology and haematology, an interactive database. Nucleic Acids Res. 28, 349-351 (Pubitemid 30047804)
37. Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., Szabo, S., Buckhaults, P., Farrell, C., Meeh, P., Markowitz, S. D., Willis, J., Dawson, D., Willson, J. K., Gazdar, A. F., Hartigan, J., Wu, L., Liu, C., Parmigiani, G., Park, B. H., Bachman, K. E., Papadopoulos, N., Vogelstein, B., Kinzler, K. W., and Velculescu, V. E. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274 (Pubitemid 44571966)
38. Akagi, K., Suzuki, T., Stephens, R. M., Jenkins, N. A., and Copeland, N. G. (2004) RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res. 32, D523-527 (Pubitemid 38081713)
39. Network, T. C. G. A. (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337
40. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., and Wold, B. (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621-628 (Pubitemid 351911867)
41. Nagaraj, N., Wisniewski, J. R., Geiger, T., Cox, J., Kircher, M., Kelso, J., Pääbo, S., and Mann, M. (2011) Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548
42. Hornbeck, P. V., Kornhauser, J. M., Tkachev, S., Zhang, B., Skrzypek, E., Murray, B., Latham, V., and Sullivan, M. (2011) PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Research 40, D261-D270
43. Kaushansky, A., Gordus, A., Chang, B., Rush, J., and MacBeath, G. (2008) A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R. Mol. Biosyst. 4, 643-653 (Pubitemid 351706308)
44. Ladbury, J. E., Lemmon, M. A., Zhou, M., Green, J., Botfield, M. C., and Schlessinger, J. (1995) Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal. Proc. Natl. Acad. Sci. U.S.A. 92, 3199-3203
45. Piccione, E., Case, R. D., Domchek, S. M., Hu, P., Chaudhuri, M., Backer, J. M., Schlessinger, J., and Shoelson, S. E. (1993) Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding. Biochemistry 32, 3197-3202 (Pubitemid 23126884)
46. Bibbins, K. B., Boeuf, H., and Varmus, H. E. (1993) Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides. Mol. Cell. Biol. 13, 7278-7287 (Pubitemid 23354251)
47. Colicelli, J. (2010) ABL tyrosine kinases: evolution of function, regulation, and specificity. Sci. Signal. 3, re6
48. Bassermann, F., Jahn, T., Miething, C., Seipel, P., Bai, R. Y., Coutinho, S., Tybulewicz, V. L., Peschel, C., and Duyster, J. (2002) Association of Bcr-Abl with the Proto-oncogene Vav Is Implicated in Activation of the Rac-1 Pathway. J. Biol. Chem. 277, 12437-12445 (Pubitemid 34952818)
49. Tidyman, W. E., and Rauen, K. A. (2009) The RASopathies: Developmental syndromes of Ras/MAPK pathway dysregulation. Curr. Opin. Genet. Dev. 19, 230-236
50. McKay, M. M., and Morrison, D. K. (2007) Integrating signals from RTKs to ERK/MAPK. Oncogene 26, 3113-3121 (Pubitemid 46763008)
51. Kleiman, L. B., Maiwald, T., Conzelmann, H., Lauffenburger, D. A., and Sorger, P. K. (2011) Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding. Mol. Cell 43, 723-737
52. Letunic, I., and Bork, P. (2011) Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy. Nucleic Acids Res. 39, W475-W478
53. Chen, W. W., Schoeberl, B., Jasper, P. J., Niepel, M., Nielsen, U. B., Lauffenburger, D. A., and Sorger, P. K. (2009) Input-output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data. Mol. Syst. Biol. 5, 239
54. Miller, M. L., Jensen, L. J., Diella, F., Jørgensen, C., Tinti, M., Li, L., Hsiung, M., Parker, S. A., Bordeaux, J., Sicheritz-Ponten, T., Olhovsky, M., Pasculescu, A., Alexander, J., Knapp, S., Blom, N., Bork, P., Li, S., Cesareni, G., Pawson, T., Turk, B. E., Yaffe, M. B., Brunak, S., and Linding, R. (2008) Linear motif atlas for phosphorylation-dependent signaling. Sci. Signal. 1, ra2
55. Raymond, E., Faivre, S., and Armand, J. P. (2000) Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy. Drugs 60. 15-23, discussion 41-42
56. Burris, H. A., 3rd, Hurwitz, H. I., Dees, E. C., Dowlati, A., Blackwell, K. L., O'Neil, B., Marcom, P. K., Ellis, M. J., Overmoyer, B., Jones, S. F., Harris, J. L., Smith, D. A., Koch, K. M., Stead, A., Mangum, S., and Spector, N. L. (2005) Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas. J. Clin. Oncol. 23, 5305-5313 (Pubitemid 46206984)
57. Degrauwe, N., Sosa, J. A., Roman, S., and Deshpande, H. A. (2012) Vandetanib for the treatment of metastatic medullary thyroid cancer. Clin. Med. Insights Oncol. 6, 243-252
58. Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J. A., Desai, J., Fletcher, C. D., George, S., Bello, C. L., Huang, X., Baum, C. M., and Casali, P. G. (14) Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 368, 1329-1338
59. Calderwood, M. A., Venkatesan, K., Xing, L., Chase, M. R., Vazquez, A., Holthaus, A. M., Ewence, A. E., Li, N., Hirozane-Kishikawa, T., Hill, D. E., Vidal, M., Kieff, E., and Johannsen, E. (2007) Epstein-Barr virus and virus human protein interaction maps. Proc. Natl. Acad. Sci. U.S.A. 104, 7606-7611 (Pubitemid 47185953)
60. Shapira, S. D., Gat-Viks, I., Shum, B. O. V., Dricot, A., de Grace, M. M., Wu, L., Gupta, P. B., Hao, T., Silver, S. J., Root, D. E., Hill, D. E., Regev, A., and Hacohen, N. (2009) A Physical and Regulatory Map of Host-Influenza Interactions Reveals Pathways in H1N1 Infection. Cell 139, 1255-1267
61. Rual, J. F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G. F., Gibbons, F. D., Dreze, M., Ayivi-Guedehoussou, N., Klitgord, N., Simon, C., Boxem, M., Milstein, S., Rosenberg, J., Goldberg, D. S., Zhang, L. V., Wong, S. L., Franklin, G., Li, S., Albala, J. S., Lim, J., Fraughton, C., Llamosas, E., Cevik, S., Bex, C., Lamesch, P., Sikorski, R. S., Vandenhaute, J., Zoghbi, H. Y., Smolyar, A., Bosak, S., Sequerra, R., Doucette-Stamm, L., Cusick, M. E., Hill, D. E., Roth, F. P., and Vidal, M. (2005) Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173-1178 (Pubitemid 41509356)
62. Venkatesan, K., Rual, J. F., Vazquez, A., Stelzl, U., Lemmens, I., Hirozane-Kishikawa, T., Hao, T., Zenkner, M., Xin, X., Goh, K.-I., Yildirim, M. A., Simonis, N., Heinzmann, K., Gebreab, F., Sahalie, J. M., Cevik, S., Simon, C., Smet, A.-S. de, Dann, E., Smolyar, A., Vinayagam, A., Yu, H., Szeto, D., Borick, H., Dricot, A., Klitgord, N., Murray, R. R., Lin, C., Lalowski, M., Timm, J., Rau, K., Boone, C., Braun, P., Cusick, M. E., Roth, F. P., Hill, D. E., Tavernier, J., Wanker, E. E., Barabási, A. L., and Vidal, M. (2009) An empirical framework for binary interactome mapping. Nature Methods 6, 83-90
63. Lennartsson, J., Wernstedt, C., Engström, U., Hellman, U., and Rönnstrand, L. (2003) Identification of Tyr900 in the kinase domain of c-Kit as a Src-dependent phosphorylation site mediating interaction with c-Crk. Experimental Cell Research 288, 110-118 (Pubitemid 36871001)
64. Krzywinski, M., Schein, J., Birol, I., Connors, J., Gascoyne, R., Horsman, D., Jones, S. J., and Marra, M. A. (2009) Circos: An information aesthetic for comparative genomics. Genome Research 19, 1639-1645